Booster shots in adults who received the Pfizer-BioNTech vaccine were highly effective at preventing symptomatic Covid-19 breakthrough infections, Pfizer announced on Thursday.The company said that out of more than 5,000 Pfizer-BioNTech vaccine recipients enrolled in its study who received a booster shot, only five later developed symptomatic disease, compared with 109 people among a similar…
